RSV
-
healthRSV Vaccine: Who Needs It and Why?
Essential facts about the RSV vaccine, including who should get it, timing, side effects, and benefits for older adults and pregnant women.
-
healthArthritis Drug Shows Promise Against RSV in Early Study
A cheap, widely available painkiller reduced RSV in the human respiratory tract, potentially offering a new treatment for the dangerous virus.
-
healthRSV Vaccine Uptake Low Among Pregnant Women in Singapore Despite Approval
Nearly two years after approval, RSV vaccine uptake among pregnant women in Singapore remains low, with no significant drop in infant hospitalizations.
-
healthMaternal RSV Vaccine: Strong Protection but Stark Disparities
New data shows maternal RSV vaccination prevented infant hospitalization, yet uptake varied sharply by race and insurance in Dallas.
-
healthMaternal RSV Vaccine Slashes Infant Hospitalizations Over 80%
New UK study reveals maternal RSV vaccination significantly cuts infant hospitalizations, especially when given weeks before birth. Important findings for preterm infants.
-
healthCanada Sees Surge in Respiratory Hospitalizations Amid Declining Vaccine Rates
Thousands hospitalized for COVID-19, flu, and RSV in Canada. Experts urge increased vaccination to ease strain on healthcare systems.
-
healthRSV Infection Window Narrowed: New Research Defines Key Transmission Period
New data reveals Respiratory Syncytial Virus (RSV) infection may only be highly infectious for around five days, impacting public health strategies and patient management.
-
healthNirsevimab Outperforms Maternal Vaccine in Reducing Infant RSV Hospitalizations
A major French study finds nirsevimab significantly lowers RSV hospitalizations and severe outcomes in infants compared to maternal vaccination, offering new clinical guidance.